Multi-Disciplinary Organization Dedicated to Promoting Advances in
Neuro-Oncology Through Research and Education

WFNOS Magazine

The inaugural issue of the official publication of the World Federation of Neuro-Oncology Societies is ...

Read Full Story

Neuro-Oncology Review Course at SNO

November 16, 2016. Register in conjunction with the SNO Annual Meeting

Read Full Story

CNS Anticancer Drug Discovery and Development Conference

Register Now!

Read Full Story
View All News


EANO 2016

Read Full Story


18th Annual Brain Tumor Update and 7th Annual International Symposium on Long-Term Control of Metastases to the Brain and Spine

Read Full Story


2nd CNS Anticancer Drug Discovery/Development Conference

Read Full Story

Basic Science

Michael Berens Ph.D.
Translational Genomics Research Institute

Genomics, invasion, preclinical models, profile-guided therapeutics

Oliver Bogler Ph.D.
M. D. Anderson Cancer Center

Signal transduction, cell death, proteomics, cytotoxic agents, animal models

Shi-Yuan Cheng Ph.D.
University of Pittsburgh Hillman Cancer Institute

Invasion, angiogenesis, signaling transduction.

Charles Cobbs M.D.
University of California San Francisco

Clinical:surgical, lab: tumor stem cells, RTK oncogenesis, signaling, viral oncogenesis 

Waldemar Debinski M.D., Ph.D.
Wake Forest University

Molecular targeting, experimental therapeutics, tumor progression/maintenance, pre-clinical models

Juan Fueyo M.D.
University of Texas MD Anderson Cancer Center

Gene therapy, cancer stem cells, cell cycle, autophagy

Frank Furnari Ph.D.
Ludwig Institute

Glioma, signal transduction, EGFR, PTEN

Saikh Haque Ph.D.
Cleveland Clinic Foundation Lerner Research Institute

Cell survival/apoptosis, Cytokine- and growth factor signaling mechanisms, brain tumor stem cells, and angiogenesis

Isa Hussaini Ph.D.
University of Virginia

Cellular and molecular biology of astrocytoma (Invasion,Cell Proliferation,Apoptosis, small molecule inhibitors and animal models)

Mark Israel M.D.
Dartmouth-Hitchcock Medical Center

Genomics, oncogenesis (oncogenes /tumor suppressor gene), animal modeling, angiogenesis, preclinical therapeutics, metabolism, biomarkers, protein/protein interactions

Martin Jadus Ph.D.
Veterans Affairs Medical Center
Immunotherapy, angiogenesis, macrophage biology, M-CSF

C. David James Ph.D.
University of California, San Francisco

Animal model therapeutic investigations, genomics, molecular and tumor biology of receptor tyrosine kinases

Robert Jenkins M.D., Ph.D.
Mayo Clinic

Genetics, biomarkers, oligodendrogliomas

Carol Kruse Ph.D.
Burnham Institute for Medical Research

Primary malignant brain tumors, gliomas, astrocytomas, immunotherapy, cellular therapy, gene therapy, suicide or cytokine gene therapy

Catherine Nutt Ph.D.
Massachusetts General Hospital

Expression profiling, molecular genetics

Hideho Okada M.D., Ph.D.
University of Pittsburgh Cancer Institute

Immunology, immunotherapy, T lymphocyte, dendritic cell, cancer vaccines

Russell Pieper Ph.D.
University of California San Francisco
Cell Signalling, drug resistance, cell cycle control
Sandra Rempel Ph.D.
Henry Ford Hospital

Invasion, ECM-tumor interactions, gliomas, meningiomas

Gregory Riggins M.D., Ph.D.
Johns Hopkins University

Genomics, drug screens, stem cellls, kinases

Charles Stiles Ph.D.  
Neural stem cells, glioma stem cells, transcription factors, signal transduction
Erwin Van Meir Ph.D.
Emory University Winship Cancer Center
Angiogenesis, hypoxia, HIF, drug discovery, oncolytic viruses, p53, pathway, tumor suppressor

Robert Wechsler-Reya Ph.D.
Duke University Medical Center
Medulloblastoma, mouse models, hedgehog, cerebellum
Please do not contact the reviewers directly.  Use the Grant  Review Application.

To volunteer as a grant reviewer, please e-mail